Table 2.
With SSDI/Medicare* (%) | Without SSDI/Medicare (%) | |
---|---|---|
Lung | n = 4,626 | n = 47,337 |
I | 22.0 | 17.8 |
II | 4.6 | 4.7 |
IIIA | 11.3 | 10.4 |
IIIB | 17.4 | 17.0 |
IV | 34.6 | 42.1 |
Unstaged | 10.2 | 8.0 |
Colorectal | n = 2,723 | n = 49,369 |
In situ | 8.6 | 8.9 |
I | 23.8 | 22.2 |
II | 21.9 | 22.7 |
III | 21.7 | 23.6 |
IV | 20.2 | 18.8 |
Unstaged | 3.9 | 3.8 |
Breast | n = 3,911 | n = 138,370 |
In situ | 14.1 | 16.4 |
I | 36.3 | 34.3 |
IIA | 21.5 | 21.6 |
IIB | 11.2 | 11.9 |
II NOS | 0.8 | 1.2 |
IIIA | 3.7 | 3.5 |
IIIB | 3.6 | 2.4 |
IV | 4.0 | 3.4 |
Unstaged | 4.9 | 5.3 |
Prostate | n = 3,811 | n = 57,448 |
In situ | 3.7 | 2.1 |
I | 21.4 | 18.7 |
II | 11.9 | 12.9 |
III | 15.0 | 20.5 |
IV | 10.5 | 10.3 |
Unstaged | 37.5 | 35.5 |
Total number of cases is: lung (n = 51,963), colorectal (n = 52,092), breast (n = 142,281), and prostate (n = 61,259).
Cases on Medicare at time of cancer diagnosis and who qualified for Medicare via SSDI.
SSDI, Social Security Disability Insurance.